Two-year course of anxiety disorders: Different across disorders or dimensions?

Acta Psychiatrica Scandinavica

Volumn 128, Issue 3, 2013, Pages 212-221

  Hendriks, Sanne M ^a   Spijker, Jan ^a,b   Licht, Carmilla M M ^c   Beekman, Aartjan T F ^c   Penninx, Brenda W J H ^c,d,e  

^a Pro Persona Mental Health Care ^*  (Netherlands)

^b NETHERLANDS INSTITUTE OF MENTAL HEALTH AND ADDICTION   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Anxiety arousal; Anxiety disorder; Avoidance behaviour; Course; Generalized anxiety disorder; Panic disorder; Social phobia

Indexed keywords

ADULT; AGED; AGORAPHOBIA; ANXIETY DISORDER; ARTICLE; AVOIDANCE BEHAVIOR; BECK ANXIETY INVENTORY; COMORBIDITY; DSM-IV; FEAR QUESTIONNAIRE; FEMALE; GENERALIZED ANXIETY DISORDER; HUMAN; INTERVIEW; LIFE CHART INTERVIEW; MAJOR CLINICAL STUDY; MALE; PANIC; PREDICTION; PRIORITY JOURNAL; PSYCHOLOGIC TEST; QUESTIONNAIRE; SOCIAL PHOBIA; SYMPTOMATOLOGY;

ANXIETY AROUSAL; ANXIETY DISORDER; AVOIDANCE BEHAVIOUR; COURSE; GENERALIZED ANXIETY DISORDER; PANIC DISORDER; SOCIAL PHOBIA;

ADULT; AGE OF ONSET; ANXIETY DISORDERS; AROUSAL; BEHAVIORAL SYMPTOMS; COMORBIDITY; DEPRESSIVE DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; ESCAPE REACTION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; OUTCOME ASSESSMENT (HEALTH CARE); PSYCHIATRIC STATUS RATING SCALES; PSYCHOTHERAPY; PSYCHOTROPIC DRUGS; QUESTIONNAIRES; SOCIOECONOMIC FACTORS;

EID: 84881554058     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/acps.12024     Document Type: Article

References (47)

1. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry 2005;62:593-602.
2. Alonso J, Angermeyer MC, Bernert S et al. Prevalence of mental disorders in Europe: results from the European study of the epidemiology of mental disorders (ESEMeD) project. Acta Psychiatr Scand Suppl 2004;420:21-27.
3. Ormel J, Petukhova M, Chatterji S et al. Disability and treatment of specific mental and physical disorders across the world. Br J Psychiatry 2008;192:368-375.
4. Bruce SE, Yonkers KA, Otto MW et al. Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study. Am J Psychiatry 2005;162:1179-1187.
5. Yonkers KA, Bruce SE, Dyck IR, Keller MB. Chronicity, relapse, and illness - course of panic disorder, social phobia, and generalized anxiety disorder: findings in men and woman from 8 years of follow-up. Depress Anxiety 2003;17:173-179.
6. Keller MB, Hanks DL. Course and outcome in panic disorder. Prog Neuro-Psychopharmacol Biol Psychiatry 1993;17:551-570.
7. Pollack MH, Otto MW. Long-term course and outcome of panic disorder. J Clin Psychiatry 1997;58(Suppl 2):57-60.
8. Woodman CL, Noyes R, Black DW, Schlosser S, Yagla SJ. A 5-year follow-up study of generalized anxiety disorder and panic disorder. J Nerv Ment Dis 1999;187:3-9.
9. Keller MB. Social anxiety disorder clinical course and outcome: review of Harvard/Brown Anxiety Research Project (HARP) findings. J Clin Psychiatry 2006;67(Suppl 12):14-19.
10. Chavira DA, Stein MB, Golinelli D et al. Predictors of clinical improvement in a randomized effectiveness trial for primary care patients with panic disorder. J Nerv Ment Dis 2009;197:715-721.
11. Katschnig H, Amering M. The long-term course of panic disorder and its predictors. J Clin Psychopharmacol 1998;18(Suppl 2):6S-11S.
12. Penninx BWJH, Nolen WA, Lamers F et al. Two-year course of depressive and anxiety disorders: results from the Netherlands Study of Depression and Anxiety (NESDA). J Affect Dis 2011;133:76-85.
13. Rego SA, Muller KL, Sanderson WC. Psychopathological mechanism across anxiety disorders. In: Salzinger K, Serper M, eds. Behavioral mechanisms and psychopathology: advancing the explanation of Its nature, cause, and treatment. Washington DC, USA: American Psychological Association, 2009.
14. Barlow DH. Anxiety and its disorders: the nature and treatment of anxiety and panic (2nd edn). New York, USA: Guildford Press, 2002.
15. den Hollander-Gijsman ME, de Beurs E, van der Wee NJA, Van Rood YR, Zitman FG. Distinguishing between depression and anxiety: a proposal for an extension of the tripartite model. Eur Psychiatry 2010;25:197-205.
16. Sherbourne C, Sullivan G, Craske MG et al. Functioning and disability in primary care outpatients with one or more anxiety disorders. Psychol Med 2010;40:2059-2068.
17. Penninx BWJH, Beekman ATF, Smit JH et al. The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods. Int J Methods Psychiatr Res 2008;17:121-140.
18. Lamers F, Hoogendoorn A, Smit J et al. Sociodemographic and psychiatric determinants of attrition in the Netherlands Study of Depression and Anxiety (NESDA). Compr Psychiatry 2012;53:63-70.
19. Wittchen HU. Reliability and validity studies of the WHO-Composite International Diagnosic Interview (CIDI): a critical review. J Psychiatr Res 1994;28:57-84.
20. Lyketsos CG, Nestadt G, Cwi J, Heithoff K, Eaton WW. The life-chart method to describe the course of psychopathology. Int J Methods Psychiatr Res 1994;4:143-155.
21. Warshaw MG, Keller MB, Stout RL. Reliability and validity of the longitudinal interval follow-up evaluation for assessing outcome of anxiety disorders. J Psychiatr Res 1994;28:531-545.
22. Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult of Clin Psychol 1988;56:893-897.
23. Marks IM, Mathews AM. Brief standard self-rating for phobic patients. Behav Res Ther 1979;17:263-267.
24. Fydrich T, Dowdall D, Chambles DL. Reliability and validity of the Beck Anxiety Inventory. J Anxiety Disord 1992;6:55-61.
25. Van Zuuren FJ. The fear questionnaire. Some data on validity, reliability and layout. Br J Psychiatry 1988;153:659-662.
26. WHO. Collaborating Centre for Drug Statistics Methodology. 2011. http://www.whocc.no/ [Accessed December 19, 2011].
27. Merikangas KR, Zhang H, Avenevoli S, Acharyya S, Neuenschwander M, Angst J. Longitudinal trajectories of depression and anxiety in a prospective community study: the Zurich Cohort Study. Arch Gen Psychiatry 2003;60:993-1000.
28. Fichter MM, Quadflieg N, Fischer UC, Kohlboeck G. Twenty-five-year course and outcome in anxiety and depression in the Upper Bavarian Longitudinal Community Study. Acta Psychiatr Scand 2010;122:75-85.
29. Rhebergen D, Batelaan NM, de Graaf R et al. The 7-year course of depression and anxiety in the general population. Acta Psychiatr Scand 2011;123:297-306.
30. Goisman RM, Warshaw MG, Peterson LG et al. Panic, agoraphobia, and panic disorder with agoraphobia: data from a multicenter anxiety disorders study. J Nerv Men Dis 1994;182:72-79.
31. Keller MB, Yonkers KA, Warshaw MG et al. Remission and relapse in subjects with panic disorder and panic with agoraphobia: a prospective short-interval naturalistic follow-up. J Nerv Ment Dis 1994;182:290-296.
32. Kikuchi M, Komuro R, Oka H, Kidani T, Hanaoka A, Koshino Y. Panic disorder with and without agoraphobia: comorbidity within a half-year of the onset of panic disorder. Psychiatry Clin Neurosci 2005;59:639-643.
33. Bruce SE, Machan JT, Dyck I, Keller MB. Infrequency of "pure" GAD: impact of psychiatric comorbidity on clinical course. Depress Anxiety 2001;14:219-225.
34. Yonkers KA, Massion AO, Warshaw MG, Keller MB. Phenomenology and course of generalized anxiety disorder. Br J Psychiatry 1996;168:308-313.
35. Wittchen HA, Zhao S, Kessler RC, Eaton WW. DSM-III-R generalized anxiety disorder in the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:355-364.
36. Brown TA, Barlow DH, Liebowitz MR. The empirical basis of generalized anxiety disorder. Am J Psychiatry 1994;151:1272-1280.
37. Keller MB. The long-term clinical course of generalized anxiety disorder. J Clin Psychiatry 2002;63(Suppl 8):11-16.
38. Weisberg RB. Overview of generalized anxiety disorder: epidemiology, presentation, and course. J Clin Psychiatry 2009;70(Suppl 2):4-9.
39. Simon NM. Generalized anxiety disorder and psychiatric comorbidities such as depression, bipolar disorder, and substance abuse. J Clin Psychiatry 2009;70(Suppl 2):10-14.
40. Rubio G, Lopez-Ibor JJ. Generalized anxiety disorder: a 40-year follow-up study. Acta Psychiatr Scand 2007;115:372-379.
41. Krueger RF. The structure of common mental disorders. Arch Gen Psychiatry 1999;56:921-926.
42. Vollebergh WAM, Iedema J, Bijl RV, De Graaf R, Smit F, Ormel J. The structure and stability of common mental disorders. Arch Gen Psychiatry 2001;58:597-603.
43. Kendler KS. Major depression and generalised anxiety disorder. Same genes, (partly) different environments - revisited. Br J Psychiatry 1996;168(Suppl 30):68-75.
44. Kendler KS, Gardner CO, Gatz M, Pederson NL. The sources of co-morbidity between major depression and generalized anxiety disorder in a Swedish national twin sample. Psychol Med 2007;37:453-462.
45. Borkovec TD, Roemer L. Perceived functions of worry among generalized anxiety disorder subjects: distraction from more emotionally distressing topics? J Behav Ther Exp Psychiatry 1995;26:25-30.
46. Dugas MJ, Gagnon F, Ladouceur R, Freeston MH. Generalized anxiety disorder: a preliminary test of a conceptual model. Behav Res Ther 1998;36:215-226.
47. White KS, Brown TA, Somers TJ, Barlow DH. Avoidance behaviour in panic disorder: de moderating influence of perceived control. Behav Res Ther 2006;44:147-157.